Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel

NCT06127108 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.

NCT NCT06127108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06127108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel
Lead sponsor
Abbott Rapid Dx
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2023
Completion date
February 2, 2024
Enrollment
447 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza a, influenza b